Clinical Trial Update: STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes recruitment for STC-15 in combination with toripalimab for selected advanced cancers and as monotherapy in selected sarcomas (P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dedifferentiated Liposarcoma
• Leiomyosarcoma
• Sarcoma
• Solid Tumor

Drugs mentioned

• STC-15 (STC-15)
• Toripalimab (Toripalimab)

Snippet

Sponsor: STORM Therapeutics LTD | Conditions: Solid Tumor, Sarcoma | Phase 1, Phase 2 | Status: RECRUITING